Short-Term Rivastigmine Treatment Reduces EEG Slow-Wave Power in Alzheimer Patients
- 1 May 2001
- journal article
- clinical trial
- Published by S. Karger AG in Neuropsychobiology
- Vol. 43 (4) , 273-276
- https://doi.org/10.1159/000054902
Abstract
The effects of a 5-day treatment with rivastigmine on the resting EEG power spectrum were studied in 15 mildly to moderately ill Alzheimer patients. In these patients, beta power was positively correlated with cognitive performance and negatively correlated with functional impairment. Rivastigmine produced a decrease in delta and theta power with no effect of hemisphere and electrode position. Delta power decrease reflects the cerebral cholinergic action of rivastigmine and may thus allow a quantitative assessment of its CNS effects.Keywords
This publication has 12 references indexed in Scilit:
- EEG Changes following Scopolamine Administration in Healthy SubjectsNeuropsychobiology, 1999
- Quantitative EEG mapping and PET in Alzheimer's diseaseJournal of the Neurological Sciences, 1992
- Test-retest reliability of the P50 mid-latency auditory evoked responsePsychiatry Research, 1991
- The cholinergic system and EEG slow wavesElectroencephalography and Clinical Neurophysiology, 1991
- The EEG spectra of Alzheimer's diseaseInternational Journal of Psychophysiology, 1991
- Computerized EEG spectral analysis in elderly normal, demented and depressed subjectsElectroencephalography and Clinical Neurophysiology, 1986
- Power spectral analysis and cortical coupling of EEG for young and old normal adultsNeurobiology of Aging, 1985
- Quantitative analysis of occipital EEG in different stages of Alzheimer's diseaseElectroencephalography and Clinical Neurophysiology, 1985
- Frequency analysis of the resting awake EEG in mild senile dementia of Alzheimer typeElectroencephalography and Clinical Neurophysiology, 1983
- “Mini-mental state”Journal of Psychiatric Research, 1975